First detailed analysis of predictors of response in HBeAg-negative chronic hepatitis B: Data from a multicenter, randomized, partially double-blind study of peginterferon alfa-2a (40KD) (PEGASYS (R)) alone or in combination with lamivudine vs lamivudine alone

Bonino, F.Lau, G.Macellin, P.Hadziyannis, S.Kitis, G.Jin, R.Yao, G.B.Piratvisuth, T.Germanidis, G.Yurdaydın, CihanDiago, M.Lai, M.McCloud, P.Brunetto, M.R.Farci, P.2022-05-052022-05-052004-10Bonino, F. vd. (2004). “First detailed analysis of predictors of response in HBeAg-negative chronic hepatitis B: Data from a multicenter, randomized, partially double-blind study of peginterferon alfa-2a (40KD) (PEGASYS (R)) alone or in combination with lamivudine vs lamivudine alone”. Hepatology, 40(4), Supplement 1, 659A-659A.0270-9139http://hdl.handle.net/11452/26289Bu çalışma, 29 Ekim- 2 Kasım 2004 tarihleri arasında Boston[Amerika Birleşik Devletleri]'da düzenlenen 55. Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)'de bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessGastroenterology and hepatologyFirst detailed analysis of predictors of response in HBeAg-negative chronic hepatitis B: Data from a multicenter, randomized, partially double-blind study of peginterferon alfa-2a (40KD) (PEGASYS (R)) alone or in combination with lamivudine vs lamivudine aloneMeeting Abstract000224102101144659A659A404, Supplement 1Gastroenterology and hepatology